JPMorgan Chase & Co. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by JPMorgan Chase & Co. on November 23, 2005, reporting an event that occurred on October 20, 2005. The filing details the entry into a material definitive agreement regarding executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a specific stock-based compensation award.
Material Changes and Executive Awards
On October 18, 2005, the Compensation & Management Development Committee approved the grant of Stock Appreciation Rights (SARs) to 14 executive officers, effective October 20, 2005. Key terms include:
- Grant Price: $34.78 per share (average of high and low selling prices on October 20, 2005).
- Settlement: SARs will be settled in shares of JPMC common stock.
- Vesting Schedule: 1/3 of the SARs become exercisable on the third, fourth, and fifth anniversaries of the grant date.
- Termination Date: October 20, 2015.
The specific awards granted were:
- Steven D. Black: 350,000 SARs
- Charles W. Scharf: 350,000 SARs
- William T. Winters: 350,000 SARs
- Michael J. Cavanagh: 250,000 SARs
- Ina Drew: 250,000 SARs
- Joan Guggenheimer: 250,000 SARs
- Samuel Todd Maclin: 250,000 SARs
- Jay Mandelbaum: 250,000 SARs
- Heidi Miller: 250,000 SARs
- James E. Staley: 250,000 SARs
- Austin A. Adams: 150,000 SARs
- John J. Farrell: 150,000 SARs
- William H. McDavid: 150,000 SARs
- Don M. Wilson III: 150,000 SARs
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items beyond the standard terms of the SAR agreements.
Investor Verification Checklist
- Verify the Form 4 filings submitted on October 24, 2005, for detailed transaction records.
- Confirm the total number of SARs granted (3,100,000) against the company's total outstanding equity.
- Review the specific award agreements for any additional performance conditions not detailed in this summary.
- Monitor the vesting schedule to assess future dilution impacts on the third, fourth, and fifth anniversaries of the grant.